This article is more than 5 years old. Information may no longer be current.
Kimmel Cancer Center appoints director of thoracic oncology
Click Here to Manage Email Alerts
Julie Brahmer, MD, a medical oncologist with extensive experience in the use of immunotherapies to treat lung cancer, has been named director of the thoracic oncology program at the Johns Hopkins Kimmel Cancer Center.
Jule Brahmer
Brahmer will lead a multidisciplinary team of physicians, nurses, researchers and fellows developing new treatments for lung and esophageal cancer and mesothelioma. She will oversee the opening of the new Thoracic Center of Excellence at Johns Hopkins Bayview Medical Center, as well as laboratory research and clinical trials.
“Dr. Brahmer has established herself as an international leader in the field of immunotherapy for lung cancer,” William Nelson, MD, PhD, director of the Kimmel Cancer Center, said in a press release. “She is poised to lead an impressive group of cancer care professionals dedicated to bringing the most innovative treatments to patients.”
Brahmer has been a faculty member at Johns Hopkins since 2001.
“The Johns Hopkins Kimmel Cancer Center is a special place, with committed experts dedicated to bringing the best treatments to patients through research and clinical trials,” Brahmer said in the press release. “I am honored to be part of this team and to help lead us into the next phase of cancer medicine.”